For Financial Professionals in the US

JFNIX Global Life Sciences Fund

By understanding the science and business of health care, our experienced team invests in companies addressing unmet medical needs or improving efficiencies

NAV
$70.55
As of 04/19/2021

1-Day Change
-$0.23 (-0.32%)
As of 04/19/2021

YTD Return
-1.33%
As of 04/19/2021

Morningstar Rating

As of 03/31/2021

Quicklinks

Overview

ABOUT THIS FUND

This global health care fund seeks consistent returns by investing in companies addressing unmet medical needs or making the health care system more efficient. We balance the portfolio across pharmaceuticals, biotechnology and services/devices sub-sectors in an effort to achieve consistent outperformance of the benchmark and peers.

WHY INVEST IN THIS FUND

Finding Growth in Health Care

The long-term drivers of growth in the health care sector include rapidly
accelerating innovation addressing unmet medical needs, powerful global demographic trends and the globalization of health care. Within this environment, the Global Life Sciences Fund seeks to invest in growth companies that are addressing unmet medical needs or making the health care system more efficient and cost effective.

Dedicated Sector Experts

Our dedicated team of analysts has 95 years of combined experience investing in health care companies. In this complex and rapidly growing sector, we believe it is critical to have an experienced team that seeks to understand both the science and the business of the companies in which they invest.

Deep and Disciplined

We believe the combination of deep, fundamental research and disciplined portfolio construction will lead to consistently strong results relative to both the health care sector and the broader equity market. The fund is balanced across the sub-sectors of health care and diversified across market-cap segments and geographies.

PORTFOLIO MANAGEMENT

Andy Acker, CFA

Andy Acker, CFA

Portfolio Manager

Industry since 1996. Joined Firm in 1999.

Performance

RETURNS (%) (As of 03/31/2021)
Global Life Sciences Fund - Class I Shares MSCI World Health Care Index S&P 500® Index
 
3M YTD 1YR 3YR 5YR 10YR Since Inception
(12/31/1998)
Global Life Sciences Fund - Class I Shares -2.66 -2.66 41.59 16.73 15.47 17.63 12.13
MSCI World Health Care Index 0.72 0.72 29.16 13.51 11.60 13.02 6.84
S&P 500® Index 6.17 6.17 56.35 16.78 16.29 13.91 7.44
Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold.
Performance for Class I Shares that includes periods prior to 7/6/09 reflects the performance of one or more share classes of the Fund or a predecessor fund, adjusted, where applicable and permitted, for differing fees and expenses. See the Fund’s prospectus for further details.
Returns include reinvestment of dividends and capital gains. Returns greater than one year are annualized.
High absolute short-term performance is not typical and may not be achieved in the future. Such results should not be the sole basis for evaluating material facts in making an investment decision.
RETURNS (%) (As of 03/31/2021)
Global Life Sciences Fund - Class I Shares MSCI World Health Care Index S&P 500® Index
 
3M YTD 1YR 3YR 5YR 10YR Since Inception
(12/31/1998)
Global Life Sciences Fund - Class I Shares -2.66 -2.66 41.59 16.73 15.47 17.63 12.13
MSCI World Health Care Index 0.72 0.72 29.16 13.51 11.60 13.02 6.84
S&P 500® Index 6.17 6.17 56.35 16.78 16.29 13.91 7.44
Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold.
Performance for Class I Shares that includes periods prior to 7/6/09 reflects the performance of one or more share classes of the Fund or a predecessor fund, adjusted, where applicable and permitted, for differing fees and expenses. See the Fund’s prospectus for further details.
Returns include reinvestment of dividends and capital gains. Returns greater than one year are annualized.
High absolute short-term performance is not typical and may not be achieved in the future. Such results should not be the sole basis for evaluating material facts in making an investment decision.
CALENDAR YEAR RETURNS (%)
Global Life Sciences Fund - Class I Shares MSCI World Health Care Index
2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Global Life Sciences Fund - Class I Shares 7.30 24.84 55.97 34.93 8.42 -12.27 22.66 4.41 29.28 25.60
MSCI World Health Care Index 9.46 17.54 36.27 18.10 6.60 -6.81 19.80 2.51 23.24 13.52

MORNINGSTAR PERCENTILE

(As Of 03/31/2021)
1 YR 3 YR 5 YR 10 YR SINCE INCEPTION
Percentile Ranking 50 30 38 22 16
Health Category|Rank/Count 64/160 33/141 44/136 19/121 7/57
(As Of 03/31/2021)
1 YR 3 YR 5 YR 10 YR SINCE INCEPTION
Percentile Ranking 50 30 38 22 16
Health Category|Rank/Count 64/160 33/141 44/136 19/121 7/57
GROWTH OF A HYPOTHETICAL INVESTMENT
Source: Morningstar, Inc.
This graph compares the performance of a hypothetical $10,000 investment in the fund, the fund’s Morningstar category average and its benchmark(s).

RETURNS-BASED STATISTICS (As of 03/31/2021 Class I Shares)

RISK / REWARD
VS. MSCI World Health Care Index		 3YR 5YR
Information Ratio 0.45 0.59
Alpha 2.40 2.78
Tracking Error 7.18 6.57
Beta 1.06 1.09
R-squared (%) 83.30 83.36
UP/DOWN MARKET CAPTURE (%)
VS. MSCI World Health Care Index		 3YR 5YR
Up Capture Ratio 113.25 117.71
Down Capture Ratio 102.09 101.92
STANDARD DEVIATION 3YR 5YR
Global Life Sciences Fund 17.43 15.85
MSCI World Health Care Index 15.02 13.29
SHARPE RATIO 3YR 5YR
Global Life Sciences Fund 0.88 0.90
MSCI World Health Care Index 0.80 0.79
ANNUAL FEES & EXPENSES (As of Fiscal Year End, 09/30/20)
CLASS I SHARES
Management Fees 0.64%
Other Expenses 0.12%
Total Gross Expenses 0.76%
Total Net Expenses 0.76%

Portfolio

Index represents the MSCI World Health Care Index.

Top Holdings (As of 03/31/2021)
% of Fund
UnitedHealth Group Inc 4.01
AstraZeneca PLC 3.87
AbbVie Inc 3.22
Merck & Co Inc 2.98
Roche Holding AG 2.78
Novartis AG (ADR) 2.77
Humana Inc 2.56
Abbott Laboratories 2.47
Boston Scientific Corp 2.46
Vertex Pharmaceuticals Inc 2.30
Total 29.42
View Full Holdings
Portfolio Characteristics (As of 03/31/2021)
  FUND INDEX
Number of Holdings
Equity Issues		 134 158
Market Capitalization
Weighted Average		 $97.61B $139.91B
Portfolio Turnover Rate
(1-year trailing)		 41.61% -
Price/Earnings Ratio
(1-year forward)		 22.38 22.96
Price/Book Ratio
(1-year forward)		 6.27 6.78
Earnings Growth Rate
(1-year forward)		 15.04% 13.01%
Sector Allocation % OF FUND % of Index % OF FUND % of Index (As of 03/31/2021)
Health Care 99.30 100.00
Financials 0.09 -
Cash & Equivalents 0.61 -
Regional Allocations % OF FUND % of Index % OF FUND % of Index (As of 03/31/2021)
North America 81.75 70.84
Europe 15.27 20.80
Japan 1.69 6.06
Asia/Pacific Ex Japan 0.68 2.11
Cash & Equivalents 0.61 -
MARKET CAPITALIZATION RANGE OF EQUITY HOLDINGS % OF FUND % OF INDEX % OF FUND % OF INDEX (As of 03/31/2021)
Over $100B 35.91 49.52
$50B to $100B 15.34 23.18
$10B to $50B 16.89 25.24
$5B to $10B 10.26 1.64
$1B to $5B 11.31 0.15
$500M to $1B 1.42
$250M to $500M 0.22
N/A 8.04 0.27
Developed VS Emerging Markets % OF FUND % of Index % OF FUND % of Index (As of 03/31/2021)
U.S. 81.51 70.58
Non-U.S. Developed 17.20 29.42
Non-U.S. Emerging 0.68 -
Cash & Equivalents 0.61 -

Documents

Related Insights

Our intellectual capital is readily available and central to our Knowledge Shared approach"
Related Insights
Investing in health care post COVID-19
June 2020
Global Perspectives

Investing in health care post COVID-19

Health care’s aggressive efforts to address COVID-19 could have a positive impact on the sector long term, says Portfolio Manager Andy Acker.

Read More

A New Era for Health Care

A New Era for Health Care

A growing understanding of the human genome and robust computing power are helping transform the health care sector unlike ever before.

Read More

Health care’s innovation shifts into high gear
April 2021
Global Perspectives Coronavirus Healthcare

Health care’s innovation shifts into high gear

Portfolio Manager Andy Acker explores the unprecedented number of medical breakthroughs occurring in health care and what it means for the sector.

Read More

TOP